chevron_leftBack
A
As of 28 June 2026, Apotex Health Corp. has a market cap of $4.99B USD, ranking #3772 globally and #114 in Canada.
It ranks #292 in the Healthcare sector, and #110 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$4.99BUSD
7.09B CAD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 8.3% | 13% | 20% | 20% | 20% | 20% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
APTX
ISIN: CA03772D1015
Shares Out.:
Shares Outstanding:
228.499M1
Shares Float:
43.391M2
|
33.61 CAD | |
|
APTX
ISIN: CA03772D1015
|
33.54 CAD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: XENE
|
$5.39B
7.9%
|
-
|
|
TSX: GUD
|
$510.9M
-90%
725.1M CAD
|
-
|
|
NASDAQ: MIST
|
$223.22M
-96%
|
-
|
|
TSX: MSCL
|
$152.79M
-97%
216.85M CAD
|
-
|
|
NASDAQ: EDSA
|
$141.28M
-97%
|
-
|
|
TSXV: RX
|
$116.86M
-98%
165.86M CAD
|
18.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
15K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
11K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
7K%
|
97.4
|
|
SIX: RO
|
$316.45B
6K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.53B
6K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
5K%
|
15.1
|
chevron_leftBack